← Back to Clinical Trials
Recruiting NCT06807203

NCT06807203 Motor-voice Assessment in Infants (MAMI)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06807203
Status Recruiting
Phase
Sponsor Ohio State University
Condition Cerebral Palsy Infantile
Study Type OBSERVATIONAL
Enrollment 46 participants
Start Date 2025-10-22
Primary Completion 2028-01-28

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 10 Days
Study Type OBSERVATIONAL
Interventions
Behavioral observation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 46 participants in total. It began in 2025-10-22 with a primary completion date of 2028-01-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to discover features of normal and disordered motor-voice profiles that are biobehavioral markers of physical disability in infants.. The main questions it aims to answer are: Identify voice factors among infants with newborn-detectable risk. Identify association between individual characteristics (Gestational age at birth, global function, motor-function) and voice factors. Examine unique features of voice production that are present in infants with high-risk for Cerebral Palsy (CP). Participants will be asked to upload a 3-minute videos of their child at term-age, 3.5-, and 9-months of age. At the 3.5-month and 9-month time point parents can choose to attend an optional in-person assessment with their child.

Eligibility Criteria

Inclusion Criteria: * gestational age of 24 0/7 - 41 6/7, * admitted to the NICU, * medically stable by 40 weeks of gestation (including off ventilator support), * born to mothers 18 - 43 years old at the time of birth, * one parent fluent in English. Exclusion Criteria: * diagnosis of a genetic syndrome (e.g. Trisomy 21), * musculoskeletal deformity, * failed hearing screen.

Frequently Asked Questions

Who can join the NCT06807203 clinical trial?

This trial is open to participants of all sexes, up to 10 Days, studying Cerebral Palsy Infantile. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06807203 currently recruiting?

Yes, NCT06807203 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ohio State University to inquire about joining.

Where is the NCT06807203 trial being conducted?

This trial is being conducted at Columbus, United States.

Who is sponsoring the NCT06807203 clinical trial?

NCT06807203 is sponsored by Ohio State University. The trial plans to enroll 46 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology